Literature DB >> 12804107

Prevalence of cancer in follicular thyroid nodules: is there still a role for intraoperative frozen section analysis?

Fabio Monzani1, Nadia Caraccio, Pietro Iacconi, Pinuccia Faviana, Angela Dardano, Fulvio Basolo, Paolo Miccoli.   

Abstract

The optimal surgical management of follicular thyroid nodules and the effectiveness of frozen section (FS) analysis in planning the operation are still controversial. In this study, we reviewed the prevalence of cancer in 309 consecutive patients (230 females, 79 males, aged 42 +/- 13 years) with follicular nodules at fine-needle aspiration cytology (FNAC) and the efficacy of FS evaluation in selecting cancers. On the whole, the prevalence of cancer was 20.1%; the occurrence of follicular variants of papillary cancer (14.9%) was threefold higher than follicular cancers (5.2%). The presence of atypical features at FNAC selected nodules with a significantly higher prevalence of cancer (46.7%, p = 0.01). FS analysis was performed in 142 patients and recognized only 8 of 27 (30%) cancers, one fourth of them with atypia at FNAC. In conclusion, this study confirms a 20% overall prevalence of malignancy in patients with follicular thyroid nodules. The association of cell atypia with a follicular pattern may define a subgroup of nodules more likely to be malignant. FS was seldom effective in recognizing cancer confirming the doubt on its cost effectiveness in planning the surgical approach. Protocols aimed at a better cytologic identification of follicular variants of papillary cancer should be considered.

Entities:  

Mesh:

Year:  2003        PMID: 12804107     DOI: 10.1089/105072503321669884

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  1 in total

1.  Better understanding in the differentiation of thyroid follicular adenoma, follicular carcinoma, and follicular variant of papillary carcinoma: a retrospective study.

Authors:  Jung Hyun Yoon; Eun-Kyung Kim; Ji Hyun Youk; Hee Jung Moon; Jin Young Kwak
Journal:  Int J Endocrinol       Date:  2014-09-18       Impact factor: 3.257

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.